Agenus Inc.
NASDAQ:AGEN
Overview | Financials
Company Name | Agenus Inc. |
Symbol | AGEN |
Currency | USD |
Price | 4.05 |
Market Cap | 87,366,195 |
Dividend Yield | 0% |
52-week-range | 4 - 19.69 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Garo H. Armen Ph.D. |
Website | https://www.agenusbio.com |
An error occurred while fetching data.
About Agenus Inc.
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD